Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Exercise or conversion Chief Scientific Officer acquired 4,026 shares (option exercise)
  4. 4 Option exercise Director acquired 166,667 shares (option exercise)
  5. 4 Open-market sale Director sold 27,612,053 shares at an average $9.67 ($266,997,653)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Director sold 1,400,000 shares at an average $2.75 ($3,856,000)
  15. 4 Open-market sale Director sold 200,000 shares at $2.61 ($522,000)
  16. 4 Open-market sale Director sold 1,750,000 shares at an average $3.10 ($5,428,500)
  17. 4 Open-market sale Director sold 1,943,308 shares at an average $2.92 ($5,673,062)
  18. 4 Open-market sale Director sold 3,406,692 shares at an average $2.92 ($9,962,929)
  19. 4 Open-market sale Director sold 250,000 shares at an average $2.53 ($632,000)
  20. 4 Open-market sale Director sold 2,650,000 shares at an average $2.68 ($7,089,425)

Page 8 of 28 · 550 filings